October 7, 2020
A team from the San Diego Supercomputer Center at UC San Diego contributed to a study led by the Vanderbilt Vaccine Center on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens, including Coronavirus SARS-CoV-2.
July 1, 2021
Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.
December 2, 2013
…a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this…
August 28, 2017
…This approach could be used to improve how well vaccines and immunotherapies work and how long they last.
April 9, 2013
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
October 26, 2017
…and physicians at Moores Cancer Center at UC San Diego Health, in partnership with colleagues at MD Anderson Cancer Center in Texas, Johns Hopkins University in Maryland and elsewhere, have been awarded a $7 million grant over four years by Stand Up to Cancer (SU2C) to create a “dream team”…
October 12, 2018
…stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune…
May 19, 2016
Immunology – and the idea that many diseases can best be addressed by boosting the body’s own immune response – is one of the hottest areas in medical research and clinical treatment. University of California San Diego School of Medicine and Chiba University School of Medicine in Japan have announced…
October 15, 2020
…When Will a COVID-19 Vaccine Be Ready? UC San Diego’s fall plan continues to evolve, informed by the university’s Return to Learn program. We invited students, faculty and staff to submit their questions, including how UC San Diego is involved in COVID-19 vaccine development, when a vaccine may be approved,…
January 25, 2023
For the first time, researchers at UC San Diego have created an atomic-level computer model of the H1N1 virus that reveals new vulnerabilities, suggesting possible strategies for the design of future vaccines and antivirals against influenza.
